Translate
Spero Therapeutics, Inc.
About
Spero Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 26 2026
Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update
Mar 18 2026
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
Dec 19 2025
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
Nov 28 2025
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 13 2025
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
Recent Videos
Spero Therapeutics: Big Wins & Future Hopes!
Apr 30, 2026
2025-05-28 12:25:00 SPRO Level 2 and Time & Sales
Apr 25, 2026
2025-05-28 07:01:41 SPRO Level 2 and Time & Sales
Apr 25, 2026
Cómo invertir en Spero Therapeutics Inc (SPRO) paso a paso
Feb 27, 2026